–
Fate Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−217
FY22:
−308
FY23:
−191
FY24:
−210
FY25:
−148
(positive)
Change from FY21 to FY25
millions USD
FY21:
−215
FY22:
−315
FY23:
−175
FY24:
–
FY25:
−135
(positive)
Change from FY21 to FY25
millions USD
FY21:
−212
FY22:
−282
FY23:
−161
FY24:
–
FY25:
−136
(positive)
Change from FY21 to FY25
millions USD
FY21:
−212
FY22:
−282
FY23:
−161
FY24:
−186
FY25:
−136
All amounts in millions USD